Skip to content

EyePoint, Inc. EYPT Debt Repayments

Debt Repayments at other companies

Merck & Co. logo
Merck & Co.MRK
$1.14B-54.4%
LQD
Liquidia CorporationLQDA
$19.97M+841%
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$0-100%
Bausch + Lomb logo
Bausch + LombBLCO
$2.81B+27,950%
United Therapeutics logo
United TherapeuticsUTHR
$0-100%
Sarepta Therapeutics, Inc. logo
Sarepta Therapeutics, Inc.SRPT
$250M

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: EyePoint, Inc. ’s 10-K, filed March 6, 2025, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's debt repayments?
EyePoint, Inc. (EYPT) reported debt repayments of $0 in Q4 2024.
How has EyePoint, Inc. 's debt repayments changed year-over-year?
EyePoint, Inc. 's debt repayments decreased by 100.0% year-over-year, from $7.5M to $0.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.